Walleye Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95K Sell
4,628
-143,377
-97% -$3.28M ﹤0.01% 3921
2026
Q1
$3.26M Buy
148,005
+50,946
+52% +$887K 0.01% 1077
2025
Q4
$1.14M Sell
97,059
-56,498
-37% -$725K ﹤0.01% 2333
2025
Q3
$2.43M Buy
+153,557
New +$2.23M 0.01% 1435
2025
Q2
Sell
-35,320
Closed -$398K 4549
2025
Q1
$478K Buy
35,320
+26,794
+314% +$445K ﹤0.01% 2600
2024
Q4
$144K Sell
8,526
-62,781
-88% -$1.22M ﹤0.01% 3948
2024
Q3
$1.45M Sell
71,307
-54,355
-43% -$1.11M ﹤0.01% 2264
2024
Q2
$2.84M Buy
125,662
+65,021
+107% +$1.7M 0.01% 1780
2024
Q1
$1.59M Buy
60,641
+33,439
+123% +$953K ﹤0.01% 2163
2023
Q4
$858K Buy
27,202
+7,244
+36% +$197K ﹤0.01% 2486
2023
Q3
$560K Buy
+19,958
New +$685K ﹤0.01% 2727
2022
Q4
Sell
-20,747
Closed -$511K 3210
2022
Q3
$511K Buy
+20,747
New +$684K 0.01% 1452
2019
Q2
Sell
-947
Closed -$27.9K 1753
2019
Q1
$35K Buy
+947
New +$34.5K 0.01% 1275

Other funds holding CC

Walleye Capital's CC Position: Q2 2026 in Review

Walleye Capital reduced its Chemours (CC) stake by 97% in Q2 2026, selling an estimated $3.28M and leaving 4,628 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3921.

Walleye Capital first reported a position in CC in Q1 2019 and has held it in 13 quarters since. The position peaked at $3.26M in Q1 2026. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Walleye Capital held 4,628 shares of Chemours worth $95K as of Q2 2026.
  • Walleye Capital sold 143,377 Chemours shares in Q2 2026, an estimated $3.28M.
  • Chemours made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3921 holding.
  • Walleye Capital first reported a position in Chemours in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's Chemours position peaked at $3.26M in Q1 2026.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.